New research suggests that limiting the pharmaceutical industry’s direct-to-consumer advertising could save more money than ...
The most expensive pharmaceuticals include Zolgensma, Zokinvy, Danyelza, Luxturna, Ravicti, Myalept, and more.
Recursion Pharmaceuticals Inc is a clinical-stage biotechnology company. The company is decoding biology by integrating ...
2h
Zacks Investment Research on MSNAscendis Pharma (ASND) Soars 10.4%: Is Further Upside Left in the Stock?Ascendis Pharma A/S (ASND) shares rallied 10.4% in the last trading session to close at $168.84. This move can be attributable to notable volume with a higher number of shares being traded than in a ...
North Carolina was among 15 states to reach the $7.4 billion settlement in January with Purdue Pharma and its owners, the ...
The finance sector is strongly represented in this year's attendees. HSBC Group Chief Executive Georges Elhedery is on the ...
2h
Zacks Investment Research on MSNRecursion Pharma Down 37% in a Month: Buy, Sell or Hold the Stock?Recursion Pharma RXRX shares have plunged 37.1% in the past month compared with the industry’s 1.4% decline. The company has also underperformed in the sector and the S&P 500 during the same time ...
Opioid victims are not getting a "fair shake" in potential $7.4 billion settlement, a claimant in the Purdue Pharmacy ...
K reports of America’s largest pharmaceutical companies show that they continue to avoid paying much, if any, U.S. corporate income tax.
Swiss pharmaceutical giant Roche said Wednesday that it had struck a deal worth up to $5.3 billion to develop Zealand ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results